Cardiff Oncology, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q1 2019 to Q4 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Cardiff Oncology, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q1 2019 to Q4 2023.
- Cardiff Oncology, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending December 31, 2023 was $796K, a 2.71% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Growth (%)